Metastatic Spine Disease: Should Patients With Short Life Expectancy Be Denied Surgical Care? An International Retrospective Cohort Study

BACKGROUND: Despite our inability to accurately predict survival in many cancer patients, a life expectancy of at least 3 mo is historically necessary to be considered for surgical treatment of spinal metastases. OBJECTIVE: To compare health-related quality of life (HRQOL) in patients surviving <...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurosurgery
Autores principales: Dea, Nicolas, Versteeg, Anne L, Sahgal, Arjun, Verlaan, Jorrit-Jan, Charest-Morin, Raphaële, Rhines, Laurence D, Sciubba, Daniel M, Schuster, James M, Weber, Michael H, Lazary, Aron, Fehlings, Michael G, Clarke, Michelle J, Arnold, Paul M, Boriani, Stefano, Bettegowda, Chetan, Laufer, Ilya, Gokaslan, Ziya L, Fisher, Charles G
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Research—Human—Clinical Studies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7360875/
https://ncbi.nlm.nih.gov/pubmed/31690935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuros/nyz472
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares